A recent study from the University of Iowa's Carver College of Medicine has shown promising results in pancreatic cancer treatment by combining high-dose intravenous vitamin C with standard chemotherapy. The study, which involved 34 patients with late-stage metastatic pancreatic cancer, found that adding 75 grams of vitamin C three times a week nearly doubled the patients' survival rates, extending life expectancy from eight to sixteen months. Furthermore, the time patients lived without disease progression increased from four to six months. High doses of vitamin C were found to generate hydrogen peroxide, which is toxic to cancer cells but relatively safe for healthy cells. This treatment also allowed patients to tolerate chemotherapy better, leading to more effective cancer cell destruction. Despite these encouraging results, experts caution that the study's small sample size and lack of diversity require further validation through larger, more diverse phase 3 trials before this approach can be widely adopted.
Cancer patient survival doubled by adding this common vitamin to chemo: study | Fox News
Catherine Colley
Contact Me
